dihydrotetrabenazine has been researched along with dextroamphetamine in 1 studies
Studies (dihydrotetrabenazine) | Trials (dihydrotetrabenazine) | Recent Studies (post-2010) (dihydrotetrabenazine) | Studies (dextroamphetamine) | Trials (dextroamphetamine) | Recent Studies (post-2010) (dextroamphetamine) |
---|---|---|---|---|---|
234 | 4 | 60 | 7,044 | 697 | 660 |
Protein | Taxonomy | dihydrotetrabenazine (IC50) | dextroamphetamine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2884 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crooks, PA; Dwoskin, LP; Teng, L | 1 |
1 other study(ies) available for dihydrotetrabenazine and dextroamphetamine
Article | Year |
---|---|
Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
Topics: Animals; Binding, Competitive; Biological Transport; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Agents; Lobeline; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Neurotransmitter Agents; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1998 |